Esentra 60mg Injection: Effective Medication for Your Needs

Esentra 60mg Injection

Active ingredient: Denosumab

Uses:

• Osteoporosis
• Bone loss due to hormonal therapy in breast or prostate cancer
• Multiple myeloma (cancer affecting plasma cells in the bone marrow)
• Bone metastases (cancer that spreads to bone)

Therapeutic effects:

• Reduces fracture risk
• Increases bone mineral density
• Improves overall bone health

Administration:

• Given as an injection by healthcare professionals
• Dosage and duration of treatment determined by a healthcare provider

Storage:

• Store in the refrigerator at a temperature between 2°C to 8°C (36°F to 46°F)
• Do not freeze
• Keep in the original package
• Keep away from light, moisture, and heat
• Keep away from children and pets

Safety advice:

• Pregnancy: safety not established; consult a doctor
• Breastfeeding: consult a healthcare provider
• Lung disorders: consult a healthcare provider
• Liver impairment: safety not extensively studied; consult a healthcare provider
• Alcohol: avoid or limit consumption
• Driving: avoid driving or operating machinery if experiencing side effects such as fatigue, dizziness, or blurred vision

Side effects:

• Serious: osteonecrosis of the jaw, atypical femoral fractures, hypocalcemia
• Common: injection site reactions, back pain, musculoskeletal pain, infections, abdominal pain, headache, hypophosphatemia

Warnings:

• Inform your doctor about all medications, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products
• Avoid taking double doses for missed doses
• Attend all scheduled appointments and follow-up visits
• Regular dental examinations and good oral hygiene practices are recommended to minimize the risk of jaw osteonecrosis

FAQs:

1. Can Esentra 60mg Injection be used in patients with a history of cancer? Esentra 60mg Injection is not recommended in patients with a history of certain cancers, such as multiple myeloma or bone metastases. Discuss your medical history and any previous or current cancer diagnoses with your healthcare provider before starting this medication.

2. Can Esentra 60mg Injection be used in patients with kidney problems? Esentra 60mg Injection is primarily eliminated through the kidneys, so caution is advised in patients with severe renal impairment or end-stage renal disease. Your healthcare provider will assess the potential risks and benefits based on your renal function.

3. Can Esentra 60mg Injection be used as a treatment for osteoporosis in men? Yes, Esentra 60mg Injection is approved for the treatment of osteoporosis in men at increased risk of fractures. It can help improve bone density and reduce fracture risk in male patients with osteoporosis.

4. Can Esentra 60mg Injection be used in children and adolescents with osteoporosis? Esentra 60mg Injection is not approved for use in children and adolescents with osteoporosis. The safety and efficacy of this medication have not been established in this population.

5. Can Esentra 60mg Injection be used in individuals with dental implants? Esentra 60mg Injection use has been associated with a slightly increased risk of jaw osteonecrosis (ONJ). If you have dental implants or are considering getting them, discuss this with your dentist and healthcare provider to assess Esentra 60mg Injection's potential risks and benefits.

6. What are the side effects of Esentra 60mg Injection? Esentra 60mg Injection can cause side effects like injection site reactions, back and musculoskeletal pain, infections, abdominal pain, headache, and low blood phosphate levels. Rare but serious side effects may include osteonecrosis of the jaw, atypical femoral fractures, hypocalcemia, and severe skin reactions.

Fact box:

• Molecule name: Denosumab
• Therapeutic class: Anti-resorptive agent
• Pharmacological class: Monoclonal Antibodies
• Indications: Osteoporosis, bone loss due to hormonal therapy in breast or prostate cancer, multiple myeloma, bone metastases

टैग्स: medical-injection, esentra-drug, pharmaceuticals, pain-relief, anti-inflammatory